BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 25, 2015
View Archived Issues
has-miR-31 shows promise as a noninvasive biomarker for pharmaco-resistant epilepsy
Read More
Innovate UK gives grant to fund Mission Therapeutics' discovery of DUB inhibitors
Read More
Microvolume RTH-258 injection effective in treating neovascular age-related macular degeneration
Read More
FDA awards grants to boost product development for rare diseases
Read More
Q BioMed to acquire Mannin Research assets, including glaucoma candidate
Read More
Concert Pharmaceuticals reports phase I results for deuterated ivacaftor CTP-656
Read More
Eisai discovers inhibitor of interaction between TRAF6 and TNF superfamily receptors
Read More
Zai Lab enters collaboration and license agreement with UCB
Read More
Nanoglobular antimicrobial shows in vivo activity against B. cepacea
Read More
Purdue Pharma and AnaBios to form joint venture in chronic pain
Read More
Fexeric approved in Europe for hyperphosphatemia in patients with chronic kidney disease
Read More
Merck & Co. unveils HIV protease inhibitors
Read More
Bayer reports new CDK inhibitors
Read More
Genentech and Constellation Pharmaceuticals introduce demethylase inhibitors
Read More
Sichuan Haisco patents Wnt signaling inhibitors
Read More
University of California and McGill University present Mcl-1 inhibitors
Read More
Helsinn Healthcare divulges ghrelin receptor antagonists
Read More
Glucose-dependent peptide shows promise for diabetes
Read More
Esteve strengthens presence in ophthalmology through deal with VSY Biotechnology
Read More
CTI BioPharma plans 2015 NDA submission for pacritinib in the treatment of myelofibrosis
Read More
VivaGel BV approved in E.U. for bacterial vaginosis
Read More
EMA committee recommends European approval of Entresto
Read More
Oral treatment for wet AMD shows potential in phase I study, moves to phase II
Read More
EMA recommends approval of mepolizumab for severe refractory eosinophilic asthma
Read More
MetaStat's MenaCalc assay predicts overall survival in axillary node-negative breast cancer
Read More
GSK and Theravance plan Japanese filing for Relvar Ellipta for COPD
Read More
EMA CHMP grants accelerated assessment of Janssen's daratumumab for MM
Read More